[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Monoclonal Antibodies In Veterinary Health Market Size study & Forecast, by Animal Type (Dogs, Others), by Application (Dermatology, Pain, Others), by End-User (Veterinary Hospitals, Others) and Regional Analysis, 2022-2029

October 2022 | 200 pages | ID: G8FE50C7E832EN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Monoclonal Antibodies In Veterinary Health Market is valued at approximately USD 0.68 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 16.7% over the forecast period 2022-2029. A monoclonal antibody is a type of antibody that is created by cloning a unique white blood cell. Monoclonal antibodies have a monovalent affinity that binds only to the same epitope. Monoclonal antibodies in veterinary health help in binding mono specifically to certain cells or proteins, imitating the animal’s natural response to attack those cells. Factors such as the growing pet population, and increasing expenditure on a pet, coupled with the rising incidences of canine atopic dermatitis are driving the market growth across the globe.

According to the Insurance Information Institute, in 2018, the total expenditure on the pet industry was estimated to account for USD 90.5 billion and the amount is constantly increasing and reached nearly USD 123.6 billion in 2021. Therefore, the increasing expenditure on a pet is leveraging the growth of Monoclonal Antibodies In Veterinary Health Market. In addition, an increasing number of initiatives by government and various private organizations, as well as growing investment in R&D activities are creating various growth prospects for the market development over the forecasting years. However, the lack of awareness and several problems associated with the Monoclonal Antibodies are hampering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Monoclonal Antibodies In Veterinary Health Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to the increasing expenditure on animal healthcare, rising number of veterinary clinics and hospitals, and the presence of leading companies. Moreover, Asia Pacific is expected to grow significantly during the forecast period. Factors such as the rising awareness regarding animal healthcare, rising prevalence of diseases in animals, along with the availability of treatment alternatives are bolstering the market demand across the region.

Major market players included in this report are:
Zoetis
Merck & Co, Inc.
Elanco Animal Health
Phibro Animal Health Corporation
Boehringer Ingelheim GmbH
Indian Immunologicals Ltd
Virbac
American Animal Health, Inc.
Hester Biosciences Limited
Colorado Serum Company

Recent Developments in the Market:
in January 2022, Zoetis publicized that its Solensia a product for pain management of osteoarthritis in cats has received the U.S. FDA approval.
In January 2022, Boehringer Ingelheim International GmbH declared the company’s collaboration with MabGenesis, with the objective of developing monoclonal antibodies for canine diseases.
Global Monoclonal Antibodies In Veterinary Health Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Animal Type, Application, End-User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Animal Type:
Dogs
Others
By Application:
Dermatology
Pain
Others
By End User:
Veterinary Hospitals
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  1.2.1. Monoclonal Antibodies In Veterinary Health Market, by Region, 2019-2029 (USD Billion)
  1.2.2. Monoclonal Antibodies In Veterinary Health Market, by Animal Type, 2019-2029 (USD Billion)
  1.2.3. Monoclonal Antibodies In Veterinary Health Market, by Application, 2019-2029 (USD Billion)
  1.2.4. Monoclonal Antibodies In Veterinary Health Market, by End-User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

CHAPTER 2. GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET DEFINITION AND SCOPE

2.1. Objective of the Study
2.2. Market Definition & Scope
  2.2.1. Scope of the Study
  2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

CHAPTER 3. GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET DYNAMICS

3.1. Monoclonal Antibodies In Veterinary Health Market Impact Analysis (2019-2029)
  3.1.1. Market Drivers
    3.1.1.1. Growing pet population
    3.1.1.2. Increasing expenditure on pet
  3.1.2. Market Challenges
    3.1.2.1. Lack of awareness
    3.1.2.2. Several problems are associated with the Monoclonal Antibodies
  3.1.3. Market Opportunities
    3.1.3.1. Increasing number of initiatives by government and various private organizations
    3.1.3.2. Growing investment in the R&D activities

CHAPTER 4. GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
  4.3.1. Political
  4.3.2. Economical
  4.3.3. Social
  4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies

CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

CHAPTER 6. GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET, BY ANIMAL TYPE

6.1. Market Snapshot
6.2. Global Monoclonal Antibodies In Veterinary Health Market by Animal Type, Performance - Potential Analysis
6.3. Global Monoclonal Antibodies In Veterinary Health Market Estimates & Forecasts by Animal Type, 2019-2029 (USD Billion)
6.4. Monoclonal Antibodies In Veterinary Health Market, Sub Segment Analysis
  6.4.1. Dogs
  6.4.2. Others

CHAPTER 7. GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET, BY APPLICATION

7.1. Market Snapshot
7.2. Global Monoclonal Antibodies In Veterinary Health Market by Application, Performance - Potential Analysis
7.3. Global Monoclonal Antibodies In Veterinary Health Market Estimates & Forecasts by Application, 2019-2029 (USD Billion)
7.4. Monoclonal Antibodies In Veterinary Health Market, Sub Segment Analysis
  7.4.1. Dermatology
  7.4.2. Pain
  7.4.3. Others

CHAPTER 8. GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET, BY END-USER

8.1. Market Snapshot
8.2. Global Monoclonal Antibodies In Veterinary Health Market by End-User, Performance - Potential Analysis
8.3. Global Monoclonal Antibodies In Veterinary Health Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
8.4. Monoclonal Antibodies In Veterinary Health Market, Sub Segment Analysis
  8.4.1. Veterinary Hospitals
  8.4.2. Others

CHAPTER 9. GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET, REGIONAL ANALYSIS

9.1. Monoclonal Antibodies In Veterinary Health Market, Regional Market Snapshot
9.2. North America Monoclonal Antibodies In Veterinary Health Market
  9.2.1. U.S. Monoclonal Antibodies In Veterinary Health Market
    9.2.1.1. Animal Type breakdown estimates & forecasts, 2019-2029
    9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
    9.2.1.3. End-User breakdown estimates & forecasts, 2019-2029
  9.2.2. Canada Monoclonal Antibodies In Veterinary Health Market
9.3. Europe Monoclonal Antibodies In Veterinary Health Market Snapshot
  9.3.1. U.K. Monoclonal Antibodies In Veterinary Health Market
  9.3.2. Germany Monoclonal Antibodies In Veterinary Health Market
  9.3.3. France Monoclonal Antibodies In Veterinary Health Market
  9.3.4. Spain Monoclonal Antibodies In Veterinary Health Market
  9.3.5. Italy Monoclonal Antibodies In Veterinary Health Market
  9.3.6. Rest of Europe Monoclonal Antibodies In Veterinary Health Market
9.4. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market Snapshot
  9.4.1. China Monoclonal Antibodies In Veterinary Health Market
  9.4.2. India Monoclonal Antibodies In Veterinary Health Market
  9.4.3. Japan Monoclonal Antibodies In Veterinary Health Market
  9.4.4. Australia Monoclonal Antibodies In Veterinary Health Market
  9.4.5. South Korea Monoclonal Antibodies In Veterinary Health Market
  9.4.6. Rest of Asia Pacific Monoclonal Antibodies In Veterinary Health Market
9.5. Latin America Monoclonal Antibodies In Veterinary Health Market Snapshot
  9.5.1. Brazil Monoclonal Antibodies In Veterinary Health Market
  9.5.2. Mexico Monoclonal Antibodies In Veterinary Health Market
9.6. Rest of The World Monoclonal Antibodies In Veterinary Health Market

CHAPTER 10. COMPETITIVE INTELLIGENCE

10.1. Top Market Strategies
10.2. Company Profiles
  10.2.1. Zoetis
    10.2.1.1. Key Information
    10.2.1.2. Overview
    10.2.1.3. Financial (Subject to Data Availability)
    10.2.1.4. Product Summary
    10.2.1.5. Recent Developments
  10.2.2. Merck & Co, Inc.
  10.2.3. Elanco Animal Health
  10.2.4. Phibro Animal Health Corporation
  10.2.5. Boehringer Ingelheim GmbH
  10.2.6. Indian Immunologicals Ltd
  10.2.7. Virbac
  10.2.8. American Animal Health, Inc.
  10.2.9. Hester Biosciences Limited
  10.2.10. Colorado Serum Company

CHAPTER 11. RESEARCH PROCESS

11.1. Research Process
  11.1.1. Data Mining
  11.1.2. Analysis
  11.1.3. Market Estimation
  11.1.4. Validation
  11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Monoclonal Antibodies In Veterinary Health Market, report scope
TABLE 2. Global Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by Animal Type 2019-2029 (USD Billion)
TABLE 4. Global Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 5. Global Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by End-User 2019-2029 (USD Billion)
TABLE 6. Global Monoclonal Antibodies In Veterinary Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Monoclonal Antibodies In Veterinary Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Monoclonal Antibodies In Veterinary Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Monoclonal Antibodies In Veterinary Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Monoclonal Antibodies In Veterinary Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Monoclonal Antibodies In Veterinary Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Monoclonal Antibodies In Veterinary Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Monoclonal Antibodies In Veterinary Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Monoclonal Antibodies In Veterinary Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Monoclonal Antibodies In Veterinary Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Monoclonal Antibodies In Veterinary Health Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Monoclonal Antibodies In Veterinary Health Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Monoclonal Antibodies In Veterinary Health Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Monoclonal Antibodies In Veterinary Health Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Monoclonal Antibodies In Veterinary Health Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Monoclonal Antibodies In Veterinary Health Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Monoclonal Antibodies In Veterinary Health Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Monoclonal Antibodies In Veterinary Health Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Monoclonal Antibodies In Veterinary Health Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Monoclonal Antibodies In Veterinary Health Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Monoclonal Antibodies In Veterinary Health Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Monoclonal Antibodies In Veterinary Health Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Monoclonal Antibodies In Veterinary Health Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Monoclonal Antibodies In Veterinary Health Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Monoclonal Antibodies In Veterinary Health Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Monoclonal Antibodies In Veterinary Health Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Monoclonal Antibodies In Veterinary Health Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Monoclonal Antibodies In Veterinary Health Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Monoclonal Antibodies In Veterinary Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Monoclonal Antibodies In Veterinary Health Market
TABLE 71. List of primary sources, used in the study of global Monoclonal Antibodies In Veterinary Health Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Monoclonal Antibodies In Veterinary Health Market, research methodology
FIG 2. Global Monoclonal Antibodies In Veterinary Health Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Monoclonal Antibodies In Veterinary Health Market, key trends 2021
FIG 5. Global Monoclonal Antibodies In Veterinary Health Market, growth prospects 2022-2029
FIG 6. Global Monoclonal Antibodies In Veterinary Health Market, porters 5 force model
FIG 7. Global Monoclonal Antibodies In Veterinary Health Market, pest analysis
FIG 8. Global Monoclonal Antibodies In Veterinary Health Market, value chain analysis
FIG 9. Global Monoclonal Antibodies In Veterinary Health Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Monoclonal Antibodies In Veterinary Health Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Monoclonal Antibodies In Veterinary Health Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Monoclonal Antibodies In Veterinary Health Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Monoclonal Antibodies In Veterinary Health Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Monoclonal Antibodies In Veterinary Health Market, regional snapshot 2019 & 2029
FIG 15. North America Monoclonal Antibodies In Veterinary Health Market 2019 & 2029 (USD Billion)
FIG 16. Europe Monoclonal Antibodies In Veterinary Health Market 2019 & 2029 (USD Billion)
FIG 17. Asia Pacific Monoclonal Antibodies In Veterinary Health Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Monoclonal Antibodies In Veterinary Health Market 2019 & 2029 (USD Billion)
FIG 19. Global Monoclonal Antibodies In Veterinary Health Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable


More Publications